Pulmonary embolism after diagnostic curettage in patient with adenomyosis and hysteromyoma: A case report and brief review of literature.
Study Goal
The researchers aimed to report a case of pulmonary embolism following diagnostic curettage in a patient with adenomyosis and hysteromyoma, focusing on the management of severe anemia with iron supplementation.
Results Summary
Iron supplementation, along with blood transfusion and erythropoietin, was used to treat severe anemia in the patient; however, the abstract does not detail specific outcomes related to iron's efficacy. The primary focus was on the occurrence and management of pulmonary embolism post-curettage.
Population
A 31-year-old Han Chinese female with adenomyosis, hysteromyoma, and severe anemia.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
blood transfusion, iron supplementation, and erythropoietin | neutral | severe anemia | A 31-year-old Han Chinese female with menstrual disorders, increased menstrual flow, and severe anemia | - | treated | #1 |
Molecular weight heparin | neutral | pulmonary embolism | patient with pulmonary embolism | 2 weeks | administered | #2 |
Molecular weight heparin | decrease | dyspnea | patient with pulmonary embolism | after 2 days of treatment | relieved significantly | #3 |
Molecular weight heparin | no change | uterine bleeding | patient with pulmonary embolism | - | did not increase | #4 |
gonadotropin-releasing hormone agonists | neutral | adenomyosis | patient with adenomyosis | after 1 week of anticoagulant therapy | administered | #5 |
gonadotropin-releasing hormone agonists | decrease | bleeding | patient with adenomyosis | - | to reduce | #6 |
follow up | no change | thrombosis | patient | 6 months | had no recurrence | #7 |
follow up | decrease | uterine bleeding | patient | 6 months | had improved | #8 |
RATIONALE: Pulmonary embolism (PE) is a common cause of cardiovascular death whose major acquired risk factors include postoperative states, pregnancy, malignancy, and age. We report a case of PE that occurred after diagnostic curettage for abnormal uterine bleeding, with a medical history of adenomyosis and hysteromyoma. PATIENT CONCERNS AND DIAGNOSES: A 31-year-old Han Chinese female was referred to our hospital with menstrual disorders, increased menstrual flow, and severe anemia. After admission, the patient was treated with a blood transfusion, iron supplementation, and erythropoietin, and diagnostic curettage was performed the following day. On the first postoperative day, the patient developed pulmonary embolism with dyspnea and fever diagnosed by CT pulmonary angiography and significantly elevated D-dimer. INTERVENTIONS AND OUTCOMES: Molecular weight heparin was administered for PE for 2 weeks, dyspnea was relieved significantly after 2 days of treatment and the uterine bleeding did not increase; and gonadotropin-releasing hormone agonists were administered for adenomyosis after 1 week of anticoagulant therapy to reduce bleeding. We followed up for 6 months, and the patient had no recurrence of thrombosis and uterine bleeding had improved. CONCLUSION: We speculate that the occurrence of pulmonary embolism was closely related to adenomyosis, hysteromyoma, and curettage in this patient. Treating the presence of both menstrual bleeding and thromboembolism is challenging, and careful management is necessary to avoid therapeutic contradictions.